| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 04/22/1998 | CN1179718A Novel pharmaceutical composition |
| 04/21/1998 | US5741893 Compositions and methods utilizing nitroxides in combination with biocompatible macromolecules |
| 04/21/1998 | US5741815 Methods for in vivo reduction of nitric oxide levels and compositions useful therefor |
| 04/21/1998 | US5741679 Regulatable nucleic acid therapeutic and methods of use thereof |
| 04/21/1998 | US5741512 Pharmaceutical compositions comprising cyclosporins |
| 04/21/1998 | US5741503 Method for regulating metabolism with dopamine beta hydroxylase inhibitors |
| 04/21/1998 | US5740793 Dry powder inhalation device with elongate carrier for power |
| 04/16/1998 | WO1998015632A1 A human protein tyrosine kinase |
| 04/16/1998 | WO1998015576A1 Platelet secretory transport protein |
| 04/16/1998 | WO1998015543A1 Aminothiazole derivatives, method of preparation and pharmaceutical compositions containing same |
| 04/16/1998 | WO1998015294A1 Mononuclear phagocytes in therapeutic drug delivery |
| 04/16/1998 | WO1998015279A1 Hormonal composition consisting of an oestrogen compound and of a progestational compound |
| 04/16/1998 | WO1998015278A1 Method for stimulating bone formation |
| 04/16/1998 | WO1998015277A2 Cns-penetrant nk-1 receptor antagonists as antidepressant and/or an anti-anxiety agents |
| 04/16/1998 | WO1998015276A1 Compositions and methods for modulating melanin production |
| 04/16/1998 | WO1998015275A2 Method and potentiated composition for treating migraine |
| 04/16/1998 | WO1998015272A1 Method for inhibiting stress-activated protein kinases |
| 04/16/1998 | WO1998015267A1 Method for the treatment of neurological or neuropsychiatric disorders |
| 04/16/1998 | WO1998015266A1 Use of bisphenolic compounds to treat type ii diabetes |
| 04/16/1998 | WO1998015184A1 Nontoxic extract of larrea tridentata and method of making the same |
| 04/16/1998 | CA2268874A1 Use of bisphenolic compounds to treat type ii diabetes |
| 04/16/1998 | CA2268417A1 Mononuclear phagocytes in therapeutic drug delivery |
| 04/16/1998 | CA2267967A1 Method for inhibiting stress-activated protein kinases |
| 04/16/1998 | CA2267646A1 Platelet secretory transport protein |
| 04/16/1998 | CA2267381A1 Method for the treatment of neurological or neuropsychiatric disorders |
| 04/16/1998 | CA2267154A1 Aminothiazole derivatives, method of preparation and pharmaceutical compositions containing same |
| 04/16/1998 | CA2266773A1 Use of a nk-1 receptor antagonist and an antidepressant and/or an anti-anxiety agent |
| 04/16/1998 | CA2266424A1 A human protein tyrosine kinase |
| 04/16/1998 | CA2242525A1 Compositions and methods for modulating melanin production |
| 04/15/1998 | EP0835937A2 Human MYT-1 kinase clone |
| 04/15/1998 | EP0835936A2 Arginyl tRNA synthase |
| 04/15/1998 | EP0835660A1 Products containing methylcobalamin for the treatment of multiple sclerosis or other demyelinating conditions |
| 04/15/1998 | EP0835656A1 Combination drug containing tramadol and a calcium channel antagonist |
| 04/15/1998 | EP0835447A1 Novel peptides and compositions which modulate apoptosis |
| 04/15/1998 | EP0835264A1 Human g-protein receptor hcegh45 |
| 04/15/1998 | EP0835135A2 Platelet-specific chimeric immunoglobulin and methods of use therefor |
| 04/15/1998 | EP0835134A1 Immunoconjugates comprising single-chain variable region fragments of anti-cd-19 antibodies |
| 04/15/1998 | EP0835127A1 Compositions and methods using myelin-associated glycoprotein (mag) and inhibitors thereof |
| 04/15/1998 | EP0835126A1 Compositions and formulations for producing analgesia and for inhibiting progression of neuropathic pain disorders |
| 04/15/1998 | EP0835111A2 Method of dynamic retardation of cell cycle kinetics to potentiate cell damage |
| 04/15/1998 | EP0835107A1 The use of alpha-1c-selective adrenoceptor agonists for the treatment of urinary incontinence |
| 04/15/1998 | EP0835106A1 Method of treating renal disease using an ace inhibitor and an aii antagonist |
| 04/15/1998 | EP0835104A1 Use of stat 5 sh2 domain specific compounds to enhance erythropoiesis |
| 04/15/1998 | EP0797442A4 Treatment of optic neuritis |
| 04/15/1998 | EP0667771B1 Antitumour compositions containing taxane derivatives |
| 04/15/1998 | CN1179103A Prilocaine and hydrofluorocarbon aerosol preparations |
| 04/14/1998 | US5739171 Method for promoting animal growth |
| 04/14/1998 | US5739113 Injecting a composition comprising a bioactive material selected from prostaglandin e, growth hormone and growth factors and a controlled release matrix; expands, softens and restores elasticity |
| 04/14/1998 | US5739110 Protection of hemopoietic cells |
| 04/14/1998 | US5739106 Appetite regulating compositions |
| 04/14/1998 | US5739009 Adipocyte-specific differentiation-related protein |
| 04/14/1998 | US5738846 Conjugating interferon to polymer strand having one or both ends activated by carbamate-or amide-forming groups |
| 04/09/1998 | WO1998014618A1 Compositions and methods for the identification and treatment of patients at risk for heart failure |
| 04/09/1998 | WO1998014598A1 INTERLEUKIN-1β CONVERTING ENZYME LIKE CYSTEINE PROTEASE |
| 04/09/1998 | WO1998014596A2 Disease associated protein tyrosine phosphatases |
| 04/09/1998 | WO1998014579A1 Rath genes and polypeptides and methods for the treatment and diagnosis of immune disorders |
| 04/09/1998 | WO1998014577A3 Nucleotide and protein sequence of mammastatin and methods of use |
| 04/09/1998 | WO1998014577A2 Nucleotide and protein sequence of mammastatin and methods of use |
| 04/09/1998 | WO1998014572A1 Novel human phospholemman-like protein |
| 04/09/1998 | WO1998014568A1 Human growth gene and short stature gene region |
| 04/09/1998 | WO1998014563A1 spsA POLYNUCLEOTIDES AND POLYPEPTIDES |
| 04/09/1998 | WO1998014461A1 NOVEL spsB |
| 04/09/1998 | WO1998014214A1 Methods for preventing, inhibiting or treating graft rejection reactions in graft-versus-host disease (gvhd) and organ transplantation |
| 04/09/1998 | WO1998014213A1 Mitochondrial membrane stabilizer |
| 04/09/1998 | WO1998014199A1 Topical products as prophylactic or curative agents for bacterial skin infections |
| 04/09/1998 | WO1998014198A1 Methods and compositions for preventing and treating heartburn |
| 04/09/1998 | WO1998014197A1 Method of inhibiting smooth muscle cell proliferation |
| 04/09/1998 | WO1998014192A1 Vitronectin receptor antagonists |
| 04/09/1998 | WO1998014186A1 Substances and their uses |
| 04/09/1998 | WO1998014179A1 Taste-masked microcapsule compositions and methods of manufacture |
| 04/09/1998 | WO1998014174A1 Protein stabilized pharmacologically active agents, methods for the preparation thereof and methods for the use thereof |
| 04/09/1998 | WO1998006435A3 COMPOSITIONS OF ANTICHLAMYDIAL AGENTS FOR THE DIAGNOSIS AND MANAGEMENT OF INFECTION CAUSED BY $i(CHLAMYDIA) |
| 04/09/1998 | WO1997048804A3 Tie-2 receptor ligands (tie ligand-3; tie ligand-4) and their uses |
| 04/09/1998 | WO1997039721A3 Methods and compositions for regulating t cell subsets by modulating transcription factor activity |
| 04/09/1998 | CA2647169A1 Human growth gene and short stature gene region |
| 04/09/1998 | CA2269079A1 Rath genes and polypeptides and methods for the treatment and diagnosis of immune disorders |
| 04/09/1998 | CA2267694A1 Method of inhibiting smooth muscle cell proliferation |
| 04/09/1998 | CA2267375A1 Mitochondrial membrane stabilizer |
| 04/09/1998 | CA2267305A1 Topical products as prophylactic or curative agents for bacterial skin infections |
| 04/09/1998 | CA2267138A1 Compositions and methods for the identification and treatment of patients at risk for heart failure |
| 04/09/1998 | CA2267097A1 Human growth gene and short stature gene region |
| 04/09/1998 | CA2265449A1 Disease associated protein tyrosine phosphatases |
| 04/09/1998 | CA2265447A1 Novel human phospholemman-like protein |
| 04/09/1998 | CA2236914A1 Interleukin-1.beta. converting enzyme like cysteine protease |
| 04/09/1998 | CA2217846A1 A combination preparation containing tramadol and a calcium channel antagonist |
| 04/08/1998 | EP0834565A2 A G-protein coupled receptor HUVCT36 |
| 04/08/1998 | EP0834556A1 Methods for culturing cells |
| 04/08/1998 | EP0834312A1 Topical medicament containing diclofenac |
| 04/08/1998 | EP0833948A1 Colon specific gene and protein |
| 04/08/1998 | EP0833914A1 Human chemokine beta-11 and human chemokine alpha-1 |
| 04/08/1998 | EP0833909A1 Protein with differentiation-inducing activity for friend's erythroleukemia cell lines |
| 04/08/1998 | EP0833892A1 Human hepatoma-derived growth factor-2 |
| 04/08/1998 | EP0833828A1 Rapamycin derivatives |
| 04/08/1998 | EP0833818A1 Cb 2? receptor agonist compounds |
| 04/08/1998 | EP0833670A2 Rotavirus enterotoxin nsp4 and methods of using same |
| 04/08/1998 | EP0833664A1 Combination of a cyclooxygenase-2 inhibitor and a leukotriene b 4? receptor antagonist for the treatment of inflammations |
| 04/08/1998 | EP0833651A1 ANALGESIC USE OF N-L-$g(a)-ASPARTYL-L-PHENYLALANINE 1-METHYL ESTER |
| 04/08/1998 | EP0833641A1 Treatment and prevention of prostatic disease |
| 04/08/1998 | EP0833636A1 Method for inhibiting neoplastic disease in mammals |
| 04/08/1998 | EP0833635A1 Novel use for pyrrole derivatives |